BioPharmSignal logoBioPharmSignal

Biotech News

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

CVRx (CVRX)CVRxConference / presentation

MINNEAPOLIS, May 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management

Open original release

Related news

CVRXCVRx2026-05-20 20:30 EST

CVRx to Present at the William Blair 46th Annual Growth Stock Conference

PLSEPulse Biosciences2026-05-27 20:05 EST

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

ANGOAngioDynamics2026-05-27 12:30 EST

AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

MLYSMineralys Therapeutics2026-06-08 20:05 EST

Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

ATRCAtriCure2026-05-27 12:00 EST

AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference

IARTIntegra LifeSciences2026-06-02 11:30 EST

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

PLSEPulse Biosciences2026-05-08 11:00 EST

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

RXSTRxSight2026-04-29 20:10 EST

RxSight, Inc. to Present at the Bank of America Healthcare Conference

NAMSNewAmsterdam Pharma2026-04-08 12:00 EST

NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference

ANGOAngioDynamics2026-03-31 12:00 EST

AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference

View all latest news

CVRx

CVRx is a medical device company focused on neuromodulation therapies for heart failure and hypertension-related conditions. Its products aim to address cardiovascular disease through implanted device technology.

Recent company news

CVRXCVRx2026-05-27 20:30 EST

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

CVRXCVRx2026-05-20 20:30 EST

CVRx to Present at the William Blair 46th Annual Growth Stock Conference

CVRXCVRx2026-05-14 12:00 EST

CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy

CVRXCVRx2026-05-11 20:05 EST

CVRx Reports First Quarter 2026 Financial and Operating Results

CVRXCVRx2026-05-04 20:30 EST

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

Stock data

Close
4.88 USD
Market cap
144.09M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States